宜联生物基于自主知识产权的TMALIN（加超链接）技术，所开发管线涵盖了发病率和死亡率最高的多个肿瘤适应症。
Project
Target
Indications
Platform
Collaboration
Discovery
Pre -Clinical
IND
Phase 1
Phase 2
Phase 3
BLA
B7H3
Solid Tumor
YL202
HER3
Solid Tumor
BioNTech
YL205
NaPi2b
Solid Tumor
YL211
C-MET
Solid Tumor
Roche
YL212
DLL3
Solid Tumor
Zai Lab
YL215
MSLN
Solid Tumor
Harbour
YL221
EGFR
Solid Tumor
Henlius
YL222
PDL1
Solid Tumor
Henlius
